References
- Cherry JD. Epidemic pertussis in 2012 – the resurgence of a vaccine-preventable disease. N Engl J Med 2012;367:785-7
- Mooi FR, Van Der Maas NA, De Melker HE. Pertussis resurgence: waning immunity and pathogen adaptation – two sides of the same coin. Epidemiol Infect 2014;142:685-94
- Gentile A, Romanin VS, Juarez Mdel V, et al. Epidemiology of Bordetella pertussis in a children's hospital. Arch Argent Pediatr 2014;112(1):26-32
- WHO. Immunization surveillance, assessment and monitoring. 2008. Available from: www.who.int/immunization_monitoring/diseases/pertussis/en/
- PAHO. Number of vaccine preventable disease (VPV) cases in the Americas. Immunization Unit. Pan American Health Organization (PAHO). Data updated as of January 30th 2012. 2012. Available from: http://aispahoorg/phip/viz/im_vaccinepreventablediseasesasp
- WHO. Review of the current whooping cough situation in the Americas, 22 March 2012. Published by the World Health Organization Global Immunization News. 2012. Available from: www.who.int/immunization/GIN_March_2012pdf 2012
- Argentina MdSdlN. Integrated Surveillance Bulletin. Sanitary and Promotion Secretary. Argentina. Available from: www.msalgovar/indexphp/home/boletin-integrado-de-vigilancia
- Brasil PS. Brasil. Alerta. 2012. Available from: http://portalsaudegovbr/portal/arquivos/pdf/informe_multi_01_08_2012_finalpdf
- México. National Center for Disease Surveillance and Control of Mexico. Epidemiological Bulletin 2012. Available from: www.dgepisaludgobmx/2010/plantilla/intd_boletinhtml
- Chile. Surveillance Unit, Department of Epidemiology. Public Health Ministry. Chile – Unidad de Vigilancia, Dpto. de Epidemiología. 2011. Available from: DIPLAS/MINSAL - INFORME DE COQUELUCHE AÑO
- Colombia. Colombia Epidemiological Bulletin of the National Institute of Health. Available from: www.insgovco/boletin-epidemiologico/boletn epidemiolgico/forms/publicaspx
- Paraguay. Paraguay General Directorate of Health Surveillance. Epidemiological Bulletin. Available from: www.vigisaludgovpy/indexphp?option=com_phocadownload&view=section&id=8&Itemid=128
- Perú. Available from: www.minsarsta.gob.pe/portal/epidemiologia/ALERTAS EPIDEMIOLOGICAS/ALERTA TOS FERINA 2013.pdf ALERTA, Epidemiológica, Fortalecimiento de vigilancia epidemiológica de la tos ferina – DISA V Lima ciudad - marzo 2013. http://www.dgegobpe/boletines/2013/15pd 2013
- Uruguay MdSPd. Ministerio de Salud Pública - Dirección General de la Salud, División de Epidemiología, Montevideo 18 de setiembre de 2012 - Informe de Actualizacion, Situación Tos Convulsa (a la semana epidemiológica 37 de 2012). Available from: www.mspgubuy/andocasociadoaspx?6628,23747
- TAG. Final report of the XIX and XX Technical Advisory Group (TAG) Meeting on Vaccine-preventable Diseases of the Pan American Health Organization. Buenos Aires, Argentina, July 2011 and Washington DC, October 2012. 2012. Available from: http://newpahoorg/hq/indexphp?option=com_content&view=article&id=1862&Itemid=1674
- Edwards KM. Overview of pertussis: focus on epidemiology, sources of infection, and long term protection after infant vaccination. Pediatr Infect Dis J 2005;24:S104-8
- Donoso A, Arriagada D, Cruces P, Diaz F. Severe pertussis: state of the art. Revista Chilena Infectol 2012;29:290-306
- TAG. A Final report of the XIX Technical Advisory Group (TAG). In: Vaccine-preventable Diseases of the Pan American Health Organization; Buenos Aires, Argentina; 2011
- ULLOA-GUTIERREZ, Rolando. Estrategias actuales de vacunación contra tos ferina en niños y adultos. Acta pediátr. costarric [online]. 2008;20(2):81-87
- Sandoval PT, Arreola Ldel P, Quechol GR, Gallardo HG. [Bordetella pertussis in adolescent students in Mexico City]. Rev Saude Publica 2008;42:679-83
- Chile. Informe de situación epidemiológica de tos ferina o coqueluche 2012. Available from: http://epiminsalcl/epi/html/bolets/reportes/Coqueluche/Coqueluche_2012pdf
- WHO. Global summary schedules. Available from: http://appswhoint/immunization_monitoring/globalsummary/schedules
- Wendelboe AM, Hudgens MG, Poole C, Van Rie A. Estimating the role of casual contact from the community in transmission of Bordetella pertussis to young infants. Emerg Themes Epidemiol 2007;4:15
- Aquino A, Martinez-Leyva G, Saltigeral P, et al. Real-time PCR-based detection of Bordetella pertussis in Mexican children and their contacts: a multicenter study. Instituto Nacional de Pediatria, Mexico City. Presented at the 52nd ICAAC 2012; 9 – 12 September 2012; San Francisco; CA; USA (Poster G3-1563)
- Flores D, Lara C Zurita E, et al. Epidemiology of pertussis in Argentina during the 2006-2010 period: trends by age group and status of vaccination. Possible source of infection. Ninth International Bordetella Symposium; 30 September – 3 October 2010; Baltimore, ML, USA
- Salud MD. Instituto Nacional de Estadísticas y Censo, Dirección de Vigilancia de la Salud, Ministerio de Salud Reportes 2006-2007. 2006
- WHO. WHO-recommended surveillance standard of pertussis. Available from: www.who.int/immunization_monitoring/diseases/pertussis_surveillance/en/
- CDC. Clinical case definition and laboratory criteria. Available from: www.cdc.gov/pertussis/surv-reportinghtml
- Gentile A. [Bordetella pertussis infection]. Arch Argent Pediatr 2010;108:78-81
- Hozbor D, Mooi F, Flores D, et al. Pertussis epidemiology in Argentina: trends over 2004-2007. J Infect 2009;59:225-31
- Debbag R, Sarti E, Espinal C, Mascareñas C. Current pertussis. epidemiological situation in Latin America and associated vaccination strategies. ESPID congress; 2013 http://www2.kenes.com/espid2013/Pages/Home.aspx
- Brasil PS. Ministério da Saúde alerta sobre a situação epidemiológica da coqueluche no Brasil. 2013. Available from: http://portalsaudesaudegovbr/portalsaude/noticia/9243/785/ms-alerta-sobre-a-situacao-epidemiologica-da-coqueluchehtml
- Chile. Report on the epidemiological situation of whooping cough Epidemiology department Chile Ministry of Health. Available from: http://epiminsalcl/vigilancia-epidemiologica/enfermedades-de-notificacion-obligatoria/coqueluche/
- Colombia. Lineamiento Estratégico para la Introducción de la Vacuna TdaP (Tétanos-Difteria-Tos ferina acelular) en el Esquema del Programa Ampliado de Inmunizaciones –PAI Para Mujeres Gestantes de las cohortes 2013 y 2014. 2013. Available from: www.minsaludgovco/Documentos y Publicaciones/Lineamiento Estrat%C3%A9gico para la Introducci%C3%B3n de la Vacuna TdaPpdf
- Ministerio de Salud de Costa Rica Estrategias de Control y Prevención de la Tosferina en Costa Rica. Documento Técnico 2009. Available from: www.ministeriodesaludgocr 2009
- Instituto Nacional de Estadísticas y Censo, Dirección de Vigilancia de la Salud, Ministerio de Salud Reportes 2007-2011. Reports of Costa Rica Ministry of Health. 2011
- México. National Epidemiological Surveillance System. Mexican Health Secretary. SINAVE
- Guatemala. Centro Nacional de Epidemiología. Ministerio de Salud Pública de Guatemala. Available from: http://epidemiologiamspasgobgt/
- Nieto Guevara J, Luciani K, Montesdeoca Melian A, et al. [Hospital admissions due to whooping cough: experience of the del nino hospital in Panama. Period 2001-2008]. An Pediatr (Barc) 2010;72:172-8
- America Academy of Pediatrics Commitee on Infectious Diseases. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine. Pediatrics 2006;117:965-78
- CDC. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months – Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep 2011;60:1424-6
- CDC. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010. MMWR Morb Mortal Wkly Rep 2011;60:13-15
- Ward JI, Cherry JD, Chang SJ, et al. Bordetella Pertussis infections in vaccinated and unvaccinated adolescents and adults, as assessed in a national prospective randomized Acellular Pertussis Vaccine Trial (APERT). Clin Infect Dis 2006;43:151-7
- CDC. Pertussis – United States, 1997–2000. MMWR Morb Mortal Wkly Rep 2002;51:737-6
- (ACIP) ACoIP. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women - Advisory Committee on Immunization Practices (ACIP). 2013. Available from: www.immunize.org/acip/aciptopic_pregasp
- CDC. Updated recommendations for the use of tetatus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women - Advisory Committee on Immunization Practices (ACIP), 2012. MMWR Morb Mortal Wkly Rep 2013;62:131-5
- Rosenblum E, McBane S, Wang W, Sawyer M. Protecting newborns by immunizing family members in a hospital-based vaccine clinic: a successful tdap cocooning program during the 2010 California pertussis epidemic. Public Health Rep 2014;129:245-51
- Hviid A, Stellfeld M, Wohlfahrt J, et al. The impact of pre-school booster vaccination of 4–6-year-old children on pertussis in 0–1-year-old children. Vaccine 2006;24:1401-7
- Fabricius G, Bergero PE, Ormazabal ME, et al. Modelling pertussis transmission to evaluate the effectiveness of an adolescent booster in Argentina. Epidemiol Infect 2013;141:718-34
- Edwards KM. Unraveling the challenges of pertussis. Proc Natl Acad Sci USA 2014;111:575-6
- Celentano LP, Massari M, Paramatti D, et al. Resurgence of pertussis in Europe. Pediatr Infect Dis J 2005;24:761-5
- He Q, Mertsola J. Factors contributing to pertussis resurgence. Future Microbiol 2008;3:329-39
- Cantarelli VV, Hoffmann ER, Fitarelli DB, et al. Pertussis: a re-emerging or under diagnosed infectious disease? Braz J Infect Dis 2013;17:385-6
- Ulloa-Gutierrez R, Hozbor D, Avila-Aguero ML, et al. The global pertussis initiative: meeting report from the Regional Latin America Meeting, Costa Rica, 5-6 December, 2008. Hum Vaccines 2010;6:876-80
- WHO. Technical advisory group on vaccine preventable diseases, XX MEETING: “Paving the Way for Immunization”, Washington DC, 17 – 19 October 2012. Available from: www.who.int/immunization/sage/meetings/2012/november/9_FINAL_TAG_Meeting_2012_reportpdf
- Skoff TH, Cohn AC, Clark TA, et al. Early Impact of the US Tdap vaccination program on pertussis trends. Arch Pediatr Adolesc Med 2012;166:344-9
- Bart MJ, Harris SR, Advani A, et al. Global population structure and evolution of Bordetella pertussis and Their relationship with vaccination. mBio 2014;5
- Fingermann M, Fernandez J, Sisti F, et al. Differences of circulating Bordetella pertussis population in Argentina from the strain used in vaccine production. Vaccine 2006;24:3513-21
- Bottero D, Gaillard ME, Fingermann M, et al. Pulsed-field gel electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms, and surfaceome analysis of vaccine and clinical Bordetella pertussis strains. Clin Vaccine Immunol 2007;14:1490-8
- Bottero D, Gaillard ME, Basile LA, et al. Genotypic and phenotypic characterization of Bordetella pertussis strains used in different vaccine formulations in Latin America. J Appl Microbiol 2012;112:1266-76
- Klein NP, Bartlett J, Fireman B, et al. Comparative effectiveness of acellular versus whole-cell pertussis vaccines in teenagers. Pediatrics 2013;131:e1716-22
- Misegades LK, Winter K, Harriman K, et al. Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010. JAMA 2012;308:2126-32
- King AJ, van Gorkom T, van der Heide HG, et al. Changes in the genomic content of circulating Bordetella pertussis strains isolated from the Netherlands, Sweden, Japan and Australia: adaptive evolution or drift? BMC Genom 2010;11:64
- Pesco P, Bergero P, Fabricius G, Hozbor D. Assessment of pertussis vaccination strategies using a mathematical model of disease transmission. Arch Argent Pediatr 2013;111:377-83